GSTT Antibodies

Santa Cruz Biotechnology provides a broad selection of GSTT Antibodies for a variety of research applications. GSTT Antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glutathione S-transferase theta (GSTT) plays a crucial role in the detoxification of harmful compounds by catalyzing the conjugation of glutathione to various substrates. GSTT significantly influences the metabolism of xenobiotics and can impact drug resistance in cancer therapy. Understanding the function and regulation of GSTT is essential for advancing therapeutic strategies and improving drug efficacy. Researchers worldwide utilize GSTT monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Current studies focusing on GSTT continue to reveal new insights into drug metabolism and resistance patterns. Ongoing research with GSTT monoclonal antibodies contributes valuable data for developing targeted therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies for GSTT support researchers in their mission to advance scientific understanding and improve human health outcomes.